Molplex Ltd. - Product Pipeline Review - 2015

Molplex Ltd. - Product Pipeline Review - 2015


Global Markets Direct’s, ‘Molplex Ltd. - Product Pipeline Review - 2015’, provides an overview of the Molplex Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Molplex Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • The report provides brief overview of Molplex Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Molplex Ltd.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Molplex Ltd.’s pipeline products
Reasons to buy
  • Evaluate Molplex Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Molplex Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Molplex Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Molplex Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Molplex Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Molplex Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Molplex Ltd. Snapshot
Molplex Ltd. Overview
Key Information
Key Facts
Molplex Ltd. - Research and Development Overview
Key Therapeutic Areas
Molplex Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Molplex Ltd. - Pipeline Products Glance
Molplex Ltd. - Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
Molplex Ltd. - Drug Profiles
Small Molecule for Infectious Mononucleosis
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Autoimmune Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Bone Lesions
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Dengue
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Diffuse Large B Cell Lymphoma
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Gram-Positive Bacterial Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Head and Neck Cancer Squamous Cell Carcinoma
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Oncology
Product Description
Mechanism of Action
R&D Progress
Molplex Ltd. - Pipeline Analysis
Molplex Ltd. - Pipeline Products by Route of Administration
Molplex Ltd. - Pipeline Products by Molecule Type
Molplex Ltd. - Dormant Projects
Molplex Ltd. - Locations And Subsidiaries
Head Office
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
List of Tables
Molplex Ltd., Key Information
Molplex Ltd., Key Facts
Molplex Ltd. - Pipeline by Indication, 2015
Molplex Ltd. - Pipeline by Stage of Development, 2015
Molplex Ltd. - Monotherapy Products in Pipeline, 2015
Molplex Ltd. - Discovery, 2015
Molplex Ltd. - Pipeline by Route of Administration, 2015
Molplex Ltd. - Pipeline by Molecule Type, 2015
Molplex Ltd. - Dormant Developmental Projects,2015
List of Figures
Molplex Ltd. - Pipeline by Top 10 Indication, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook